Document is current
Any future updates will be listed below
-
Authors
Chu, Wenxin
Wu, Minghui
Sun, Jingxia
Pan, Jiangmei
Li, Zhengming
Huang, Jianhao
Zhai, Zhenwei
Lu, Wensheng https://orcid.org/0000-0002-0212-3624
-
Funding
Funding for this research was provided by:
the Self-funded Scientific Research Project of the Health Commission of Guangxi Zhuang Autonomous Region (No. Z-A20240099)
the Self-funded Scientific Research Project of the Health Commission of Guangxi Zhuang Autonomous Region (No. Z-A20240116)
- License Information
-
More Information
Article History
Received: 18 January 2026
Accepted: 26 May 2026
First Online: 3 June 2026
Declarations
Human ethics and consent to participate: The study protocol received approval from the Ethics Committee of the Guangxi Academy of Medical Sciences & the People’s Hospital of Guangxi Zhuang Autonomous Region (Center ethics approval No. Ethics-KY-IIT-2023-60 for “The Ambispective Cohort Study on Clinical Characteristics and Prognosis in Patients with Immunoinflammation and Metabolic Diseases”). Written informed consent was obtained from all individual participants included in the study. The research was conducted in compliance with the ethical principles outlined in the Declaration of Helsinki.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
